Moderna receives Health Canada approval for updated COVID-19 vaccine targeting SARS-CoV-2 Variant LP.8.1
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
The newly launched protocol will accelerate the clinical development of stenoparib and its drug-specific Drug Response Predictor (DRP) companion diagnostic (CDx) toward potential FDA approval
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
PICCOLO trial met its primary endpoint of objective response rate (ORR)
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season
Subscribe To Our Newsletter & Stay Updated